Book I: Pharmaceutical products

The following definitions apply 1° Magistral preparation means any medicinal product prepared in accordance with a medical prescription intended for a specific patient when there is no suitable or available proprietary medicinal product, including because it is not actually marketed, which has a marketing authorisation, one of the authorisations or a compassionate prescribing framework mentioned in articles L. 5121-9-1, L. 5121-12 and L. 5121-12-1 , a parallel import authorisation or…

The following definitions apply 1° “Investigational medicinal product” means a medicinal product which has been tested or used as a reference, including as a placebo, in a clinical trial; 2° “Authorised investigational medicinal product” means a medicinal product authorised in accordance with Regulation (EC) No 726/2004, or in any Member State concerned in accordance with Directive 2001/83/EC, irrespective of changes made to the labelling of the medicinal product, which is…

The prescription of a proprietary medicinal product shall mention its active ingredients, designated by their international non-proprietary name recommended by the World Health Organisation or, failing this, their pharmacopoeial name. In the absence of such names, the usual common name is given. It may also mention the fancy name of the medicinal product. By way of derogation from the first paragraph, the prescription for one of the medicinal products mentioned…

Any holder of a marketing authorisation for a medicinal product or any operator of such a medicinal product is required, within one year of the promulgation of Act 2011-2012 of 29 December 2011 on reinforcing the safety of medicinal products and health products, to make available to the public on its website the designation of the active ingredients of this medicinal product according to their international non-proprietary name recommended by…

When it is drawn up at the request of a patient with a view to use in another Member State of the European Union, the prescription of one of the medicinal products mentioned in 6°, 14° and 15° of Article L. 5121-1, in Article L. 5121-3, and points a and d of paragraph 1 of Article 2 of Regulation (EC) No 1394/2007 of the European Parliament and of the Council…